Trial Profile
Phase I dose escalation study of hPV-19 in patients with advanced solid tumors refractory to standard therapy
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 22 Jun 2018
Price :
$35
*
At a glance
- Drugs HPV 19 (Primary)
- Indications Solid tumours
- Focus Adverse reactions; First in man; Pharmacokinetics; Therapeutic Use
- 22 Jun 2018 New trial record
- 05 Jun 2018 Results presented at the 54th Annual Meeting of the American Society of Clinical Oncology